Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FRD58
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,377
Award facts
- Contract value 100% obligated
- $6,376.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of XOLAIR 300 MG/2 ML Auto-Injector at a ceiling value of $6,376.64. This firm fixed-price delivery order, which is expected to be completed by July 14, 2025, represents a non-set-aside competitive award. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. XOLAIR (omalizumab) is a monoclonal antibody therapy used primarily for severe allergic asthma and chronic idiopathic urticaria treatment.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. As the prime contractor under this IDC, AmerisourceBergen supplies a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, vaccines, and medical devices. The company's federal contracting demonstrates significant capability in fulfilling Defense Department medical procurement requirements through competitive processes and serves multiple federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FRD58?
SPE2DB25FRD58 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 20, 2025.
How much is contract SPE2DB25FRD58 worth?
The government has obligated $6,377 on SPE2DB25FRD58.
Is contract SPE2DB25FRD58 an order under another contract?
Yes. SPE2DB25FRD58 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRD58 competed?
The extent of competition for SPE2DB25FRD58 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award